DILE is a lupus-like syndrome that occurs after exposure to certain pharmaceuticals. Unlike SLE, which is a chronic autoimmune disease, DILE is usually reversible upon discontinuation of the offending drug. The condition is characterized by symptoms such as arthralgia, myalgia, fever, and serositis, accompanied by the presence of antinuclear antibodies (ANAs).